
Werewolf Therapeutics
Oncology biotherapeutics company
Stránky společnostiRok založení
2017
Uzávěrka
7/1/2021
Ziskovost
25.31%
O společnosti
Total Funding
$128.2M
Werewolf Therapeutics is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.
Number of employees
11-50
Headquarters
Cambridge, Massachusetts, United States